{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:57Z","timestamp":1794047517409,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Mutant SF3B1 (SF3B1mut) in hematopoietic stem\/progenitor cells (HSPC) primarily affects erythropoiesis, resulting in myelodysplastic syndromes (MDS) with refractory macrocytic anemia and ring sideroblasts. SF3B1mut results in aberrant splicing of a large number of transcripts in HSPC due to the alternative use of cryptic splice sites. Aberrant splicing of Tmem14c and Abcb7 has been shown to be the cause of the ring sideroblasts. However, the key mis-spliced gene(s) that drive macrocytic anemia have not been well-determined. Mis-splicing and downregulation of TAK1 pre-mRNA was detected in SF3B- 1mut-HSPC. We found that TAK1 is required for the survival of HSPC by restricting RIPK1-dependent and -independent PANoptosis. PANoptosis was increased in bone marrow samples from SF3B1mut-MDS patients. To study whether TAK1-downregulation is the cause of anemia in SF3B1mut-MDS, we knocked down Tak1 (Tak1KD) in mouse HSPC. We found that mice transplanted with Tak1KD-HSPC developed anemia and that Ripk1 inhibition could restore blood cell counts in such anemic mice. Tak1KD-HSPC are highly sensitive to TAK1 inhibitor- or cIAP inhibitor-induced PANoptosis. Furthermore, RIPK1 inhibition could also correct differentiation and survival defects of SF3B1mut human erythroblasts. TAK1 inhibitor could also preferentially eliminate SF3B1mut HSPC from MDS patient samples. Our study suggests that SF3B1mut MDS can be treated by either inhibition of RIPK1-PANoptotic signaling to restore blood cell counts or activation of PANoptosis to eliminate the mutant HSPC.<\/jats:p>","DOI":"10.3324\/haematol.2025.287951","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:09:05Z","timestamp":1761811745000},"page":"1355-1367","source":"Crossref","is-referenced-by-count":1,"title":["TGF\u03b2-activated kinase-1 knockdown in hematopoietic stem-progenitor cells causes PANoptosis and myelodysplastic syndrome-like disease in mice"],"prefix":"10.3324","volume":"111","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Thalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameet R.","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Runde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgena","family":"Kosti-Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Breslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Long","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"87959","doi-asserted-by":"crossref","unstructured":"Sekeres MA, Taylor J. Diagnosis and treatment of myelodysplastic syndromes: a review. JAMA. 2022; 328(9):872-880.","DOI":"10.1001\/jama.2022.14578"},{"key":"87960","doi-asserted-by":"crossref","unstructured":"McQuilten ZK, Wood EM, Polizzotto MN. Underestimation of myelodysplastic syndrome incidence by cancer registries: results from a population-based data linkage study. Cancer. 2014; 120(11):1686-1694.","DOI":"10.1002\/cncr.28641"},{"key":"87961","doi-asserted-by":"crossref","unstructured":"Nazha A, Sekeres MA, Bejar R. Genomic biomarkers to predict resistance to hypomethylating agents in patients with myelodysplastic syndromes using artificial intelligence. JCO Precis Oncol. 2019; 3","DOI":"10.1200\/PO.19.00119"},{"key":"87962","doi-asserted-by":"crossref","unstructured":"Sallman DA, List A. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood. 2019; 133(10):1039-1048.","DOI":"10.1182\/blood-2018-10-844654"},{"key":"87963","doi-asserted-by":"crossref","unstructured":"Vallelonga V, Gandolfi F, Ficara F. Emerging insights into molecular mechanisms of inflammation in myelodysplastic syndromes. Biomedicines. 2023; 11(10):2613.","DOI":"10.3390\/biomedicines11102613"},{"key":"87964","doi-asserted-by":"crossref","unstructured":"Steensma DP. Graphical representation of clinical outcomes for patients with myelodysplastic syndromes. Leuk Lymphoma. 2016; 57(1):17-20.","DOI":"10.3109\/10428194.2015.1061191"},{"key":"87965","doi-asserted-by":"crossref","unstructured":"Parker JE, Mufti GJ, Rasool F. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood. 2000; 96(12):3932-3938.","DOI":"10.1182\/blood.V96.12.3932"},{"key":"87966","doi-asserted-by":"crossref","unstructured":"Basiorka AA, McGraw KL, Eksioglu EA. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Blood. 2016; 128(25):2960-2975.","DOI":"10.1182\/blood-2016-07-730556"},{"key":"87967","doi-asserted-by":"crossref","unstructured":"Wagner PN, Shi Q, Salisbury-Ruf CT. Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice. Blood. 2019; 133(2):107-120.","DOI":"10.1182\/blood-2018-05-847335"},{"key":"87968","doi-asserted-by":"crossref","unstructured":"Sharma BR, Karki R, Rajesh Y. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). J Biol Chem. 2023; 299(9):105141.","DOI":"10.1016\/j.jbc.2023.105141"},{"key":"87969","doi-asserted-by":"crossref","unstructured":"Sundaram B, Pandian N, Mall R. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMP. Cell. 2023; 186(13):2783-2801.e2720.","DOI":"10.1016\/j.cell.2023.05.005"},{"key":"87970","doi-asserted-by":"crossref","unstructured":"Lee S, Karki R, Wang Y. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021; 597(7876):415-419.","DOI":"10.1038\/s41586-021-03875-8"},{"key":"87971","doi-asserted-by":"crossref","unstructured":"Qi Z, Zhu L, Wang K. PANoptosis: emerging mechanisms and disease implications. Life Sci. 2023; 333:122158.","DOI":"10.1016\/j.lfs.2023.122158"},{"key":"87972","doi-asserted-by":"crossref","unstructured":"Cai H, Lv M, Wang T. PANoptosis in cancer, the triangle of cell death. Cancer Med. 2023; 12(24):22206-22223.","DOI":"10.1002\/cam4.6803"},{"key":"87973","doi-asserted-by":"crossref","unstructured":"Christgen S, Zheng M, Kesavardhana S. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020; 10:237.","DOI":"10.3389\/fcimb.2020.00237"},{"key":"87974","doi-asserted-by":"crossref","unstructured":"Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019; 9:406.","DOI":"10.3389\/fcimb.2019.00406"},{"key":"87975","doi-asserted-by":"crossref","unstructured":"Malcovati L, Stevenson K, Papaemmanuil E. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020; 136(2):157-170.","DOI":"10.1182\/blood.2020004850"},{"key":"87976","doi-asserted-by":"crossref","unstructured":"Lee SC, North K, Kim E. Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations. Cancer Cell. 2018; 34(2):225-241.","DOI":"10.1016\/j.ccell.2018.07.003"},{"key":"87977","doi-asserted-by":"crossref","unstructured":"Clough CA, Pangallo J, Sarchi M. Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome. Blood. 2022; 139(13):2038-2049.","DOI":"10.1182\/blood.2021012652"},{"key":"87978","doi-asserted-by":"crossref","unstructured":"Mupo A, Seiler M, Sathiaseelan V. Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts. Leukemia. 2017; 31(3):720-727.","DOI":"10.1038\/leu.2016.251"},{"key":"87979","doi-asserted-by":"crossref","unstructured":"Obeng EA, Chappell RJ, Seiler M. Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell. 2016; 30(3):404-417.","DOI":"10.1016\/j.ccell.2016.08.006"},{"key":"87980","doi-asserted-by":"crossref","unstructured":"Liu S, Joshi K, Zhang L. Caspase 8 deletion causes infection\/inflammation-induced bone marrow failure and MDS-like disease in mice. Cell Death Dis. 2024; 15(4):278.","DOI":"10.1038\/s41419-024-06660-3"},{"key":"87981","doi-asserted-by":"crossref","unstructured":"Tang M, Wei X, Guo Y. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J Exp Med. 2008; 205(7):1611-1619.","DOI":"10.1084\/jem.20080297"},{"key":"87982","doi-asserted-by":"crossref","unstructured":"Lieu YK, Liu Z, Ali AM. SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes. Proc Natl Acad Sci U S A. 2022; 119(1):e2111703119.","DOI":"10.1073\/pnas.2111703119"},{"key":"87983","doi-asserted-by":"crossref","unstructured":"Takaesu G, Inagaki M, Takubo K. TAK1 (MAP3K7) signaling regulates hematopoietic stem cells through TNF-dependent and -independent mechanisms. PLoS One. 2012; 7(11):e51073.","DOI":"10.1371\/journal.pone.0051073"},{"key":"87984","doi-asserted-by":"crossref","unstructured":"Xiao Y, Li H, Zhang J. TNF-alpha\/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells\/ progenitors into 2 distinct populations. Blood. 2011; 118(23):6057-6067.","DOI":"10.1182\/blood-2011-06-359448"},{"key":"87985","doi-asserted-by":"crossref","unstructured":"Sakamachi Y, Morioka S, Mihaly SR. TAK1 regulates resident macrophages by protecting lysosomal integrity. Cell Death Dis. 2017; 8(2):e2598.","DOI":"10.1038\/cddis.2017.23"},{"key":"87986","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang J, Ginzburg Y. Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. Blood. 2013; 121(8):e43-49.","DOI":"10.1182\/blood-2012-09-456079"},{"key":"87987","doi-asserted-by":"crossref","unstructured":"Yokomizo-Nakano T, Hamashima A, Kubota S. Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs. J Exp Med. 2023; 220(7):e20220962.","DOI":"10.1084\/jem.20220962"},{"key":"87988","doi-asserted-by":"crossref","unstructured":"DeZern AE, Pu J, McDevitt MA. Burst-forming unit-erythroid assays to distinguish cellular bone marrow failure disorders. Exp Hematol. 2013; 41(9):808-816.","DOI":"10.1016\/j.exphem.2013.04.013"},{"key":"87989","doi-asserted-by":"crossref","unstructured":"Hu J, Liu J, Xue F. Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. Blood. 2013; 121(16):3246-3253.","DOI":"10.1182\/blood-2013-01-476390"},{"key":"87990","doi-asserted-by":"crossref","unstructured":"Yan H, Ali A, Blanc L. Comprehensive phenotyping of erythropoiesis in human bone marrow: evaluation of normal and ineffective erythropoiesis. Am J Hematol. 2021; 96(9):1064-1076.","DOI":"10.1002\/ajh.26247"},{"key":"87991","doi-asserted-by":"crossref","unstructured":"Fenaux P, Platzbecker U, Mufti GJ. Luspatercept in patients with lower-risk myelodysplastic syndromes. N Engl J Med. 2020; 382(2):140-151.","DOI":"10.1056\/NEJMoa1908892"},{"key":"87992","doi-asserted-by":"crossref","unstructured":"de Thonel A, Vandekerckhove J, Lanneau D. HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood. 2010; 116(1):85-96.","DOI":"10.1182\/blood-2009-09-241778"},{"key":"87993","doi-asserted-by":"crossref","unstructured":"Dondelinger Y, Delanghe T, Rojas-Rivera D. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol. 2017; 19(10):1237-1247.","DOI":"10.1038\/ncb3608"},{"key":"87994","doi-asserted-by":"crossref","unstructured":"Menon MB, Gropengiesser J, Fischer J. p38(MAPK)\/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. Nat Cell Biol. 2017; 19(10):1248-1259.","DOI":"10.1038\/ncb3614"},{"key":"87995","doi-asserted-by":"crossref","unstructured":"Tyrkalska SD, Perez-Oliva AB, Rodriguez-Ruiz L. Inflammasome regulates hematopoiesis through cleavage of the master erythroid transcription factor GATA1. Immunity. 2019; 51(1):50-63.e5.","DOI":"10.1016\/j.immuni.2019.05.005"},{"key":"87996","doi-asserted-by":"crossref","unstructured":"Ribeil JA, Zermati Y, Vandekerckhove J. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature. 2007; 445(7123):102-105.","DOI":"10.1038\/nature05378"},{"key":"87997","doi-asserted-by":"crossref","unstructured":"Li W, Yuan J. Targeting RIPK1 kinase for modulating inflammation in human diseases. Front Immunol. 2023; 14:1159743.","DOI":"10.3389\/fimmu.2023.1159743"},{"key":"87998","doi-asserted-by":"crossref","unstructured":"Xu YR, Lei CQ. TAK1-TABs complex: a central signalosome in inflammatory responses. Front Immunol. 2020; 11:608976.","DOI":"10.3389\/fimmu.2020.608976"},{"key":"87999","doi-asserted-by":"crossref","unstructured":"Mihaly SR, Ninomiya-Tsuji J, Morioka S. TAK1 control of cell death. Cell Death Differ. 2014; 21(11):1667-1676.","DOI":"10.1038\/cdd.2014.123"},{"key":"88000","doi-asserted-by":"crossref","unstructured":"Annibaldi A, Wicky John S, Vanden Berghe T. Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2. Mol Cell. 2018; 69(4):566-580.e5.","DOI":"10.1016\/j.molcel.2018.01.027"},{"key":"88001","doi-asserted-by":"crossref","unstructured":"Malireddi RKS, Gurung P, Mavuluri J. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. J Exp Med. 2018; 215(4):1023-1034.","DOI":"10.1084\/jem.20171922"},{"key":"88002","doi-asserted-by":"crossref","unstructured":"Malireddi RKS, Gurung P, Kesavardhana S. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020; 217(3)","DOI":"10.1084\/jem.20191644"},{"key":"88003","doi-asserted-by":"crossref","unstructured":"Wang Y, Karki R, Mall R. Molecular mechanism of RIPK1 and caspase-8 in homeostatic type I interferon production and regulation. Cell Rep. 2022; 41:111434.","DOI":"10.1016\/j.celrep.2022.111434"},{"key":"88004","doi-asserted-by":"crossref","unstructured":"Runde AP, Mack R, Breslin JP. The role of TBK1 in cancer pathogenesis and anticancer immunity. J Exp Clin Cancer Res. 2022; 41(1):135.","DOI":"10.1186\/s13046-022-02352-y"},{"key":"88005","doi-asserted-by":"crossref","unstructured":"Li W, Shan B, Zou C. Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response. Cell Res. 2022; 32(7):621-637.","DOI":"10.1038\/s41422-022-00673-3"},{"key":"88006","doi-asserted-by":"crossref","unstructured":"Zou J, Shi Q, Chen H. Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis. Exp Hematol. 2021; 103:60-72.e5.","DOI":"10.1016\/j.exphem.2021.09.004"},{"key":"88007","doi-asserted-by":"crossref","unstructured":"Yamashita M, Passegue E. TNF-alpha coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell. 2019; 25(3):357-372.e7.","DOI":"10.1016\/j.stem.2019.05.019"},{"key":"88008","doi-asserted-by":"crossref","unstructured":"Pietras EM, Mirantes-Barbeito C, Fong S. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016; 18(6):607-618.","DOI":"10.1038\/ncb3346"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12962\/79019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12962\/79870","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12962\/79019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:09Z","timestamp":1794046209000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.287951","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}